ctrl K

Price Alert

Pieris Pharmaceuticals In... (PIRS)

NASDAQ: PIRS · Real-Time Price · USD

13.60

-2.51 (-15.58%)

At close: Dec 13, 2024, 10:00 PM

Pieris Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	83.6M	17.4M	38.63M	117.76M
Short-Term Investments	n/a	8.97M	20.53M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	1.37M	2.9M
Receivables	358K	572K	5.81M	3.31M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	4.27M	7.66M	8.45M	6.55M
Total Current Assets	88.23M	38.68M	73.42M	127.63M
Property-Plant & Equipment	n/a	n/a	20.7M	23.03M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	22.07M	25.93M
Total Assets	88.23M	38.68M	95.49M	153.56M
Account Payables	4.59M	3.37M	4.15M	8.61M
Deferred Revenue	n/a	n/a	20.82M	25.12M
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	7.45M	2.1M	7.73M	12.21M
Total Current Liabilities	12.04M	11.92M	36.58M	50.56M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	13.59M	n/a	n/a	n/a
Total Long-Term Liabilities	13.59M	n/a	30.98M	52.24M
Total Liabilities	25.63M	11.92M	67.56M	102.81M
Total Debt	n/a	n/a	13.1M	13.84M
Common Stock	11K	98K	74K	72K
Retained Earnings	-93.73M	-314.96M	-290.42M	-257.14M
Comprehensive Income	3K	28K	-254K	829K
Shareholders Equity	62.61M	26.76M	27.93M	50.76M
Total Investments	n/a	8.97M	20.53M	n/a